The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ruby Qc Investment Holdings Pte Ltd
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts more than Nifty Microcap 250 and 3.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ruby QC Investment Holdings Pte Ltd, a Singapore-based investor (not part of the promoter group), has sold its entire holding of 72,78,535 equity shares in Akums Drugs and Pharmaceuticals, equivalent to 4.6244% of the company's share capital. The transaction was executed as a block deal on 22 December 2025. After the sale, the investor's holding stands at nil, marking a complete exit from the company. The disclosure was filed under Regulation 29(2) of the SEBI Takeover Regulations, 2011.
A complete exit by a foreign institutional investor via a block deal means large supply hit the market at once, which can weigh on the stock price in the short term. Retail investors should note the change in shareholder base and watch for follow-up block deals or any price impact around the 22 December 2025 execution date.